TP53 and pachyonychia congenita: Combined with the network topology characteristics and the results of the module analysis of targets, this study suggests that these 4 targets (P53, VEGFA, CASP3, and JUN) are potential therapeutic targets for ADI treatment of PC and molecular docking was performed.